We know that declining estrogen levels that occur with menopause can affect individual women differently, says Dr
Things are moving especially fast, and pill versions of GLP-1 drugs are now on the market
Ideal candidates typically include: Adults with a BMI of 30 or higher (classified as obese) Adults with a BMI of 27 or higher who have at least one weight-related condition, such as type 2 diabetes, hypertension, high cholesterol, PCOS, or obstructive sleep apnea Individuals who have tried diet and exercise consistently but havent achieved meaningful weight loss Patients seeking a non-surgical, medication-based alternative to bariatric procedures People with insulin resistance, prediabetes, or blood sugar management challenges Semaglutide is not recommended for patients who are pregnant, breastfeeding, or planning to conceive, as well as those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
She said it reminded her of how taking cannabis felt when she was younger
Wegovy (semaglutide) is a GLP-1 receptor agonist licensed for weight management that commonly causes gastrointestinal side effects including nausea, diarrhoea, and constipation
/assets/images/provider/photos/2802570.png)
